Knights of Columbus Asset Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
WP
PAMS
Knights of Columbus Asset Advisors's EDIT Position: Q1 2023 in Review
Knights of Columbus Asset Advisors sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 25,985 shares — an estimated $230K sold.
Knights of Columbus Asset Advisors first reported a position in EDIT in Q4 2019 and held it in 13 quarters. The position peaked at $2.55M in Q2 2021. 235 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.
- Knights of Columbus Asset Advisors reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
- Knights of Columbus Asset Advisors sold 25,985 Editas Medicine shares in Q1 2023, an estimated $230K.
- Knights of Columbus Asset Advisors first reported a position in Editas Medicine in Q4 2019 and held it in 13 quarters.
- Knights of Columbus Asset Advisors's Editas Medicine position peaked at $2.55M in Q2 2021.
- 235 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.
Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2023, filed 1 May 2023.